[Clinical results in the treatment with metergoline in 80 hyperprolactinemic patients].
8 or 12 mg/day methergolin was administered for an average of 8 months to 80 patients with hyperprolactinaemia of tumoural (20 cases), idiopathic (39 cases), and iatrogenic (21 cases) origin. The success of the treatment was apparent in the return of ovulation and the establishment of pregnancy in 80% of patients with microadenoma, and 85% of those with a normal sella turcica.
D000236:Adenoma / Q000188:drug therapy*; D000293:Adolescent; D000328:Adult; D004305:Dose-Response Relationship, Drug; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D005687:Galactorrhea / Q000188:drug therapy; D006801:Humans; D008711:Metergoline / Q000627:therapeutic use*; D010060:Ovulation / Q000187:drug effects; D010911:Pituitary Neoplasms / Q000188:drug therapy*; D011247:Pregnancy; D011388:Prolactin / Q000097:blood*; D012658:Sella Turcica / Q000473:pathology
D004873:Ergolines; D008711:Metergoline; D011388:Prolactin
Risultati clinici del trattamento con metergolina in 80 pazienti iperprolattinemiche.